Limbic encephalitis and variants: Classification, diagnosis and treatment


Tuzun E. , DALMAU J.

NEUROLOGIST, vol.13, no.5, pp.261-271, 2007 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 13 Issue: 5
  • Publication Date: 2007
  • Doi Number: 10.1097/nrl.0b013e31813e34a5
  • Title of Journal : NEUROLOGIST
  • Page Numbers: pp.261-271
  • Keywords: limbic encephalitis, paraneoplastic, nonparaneoplastic, antibodies, PARANEOPLASTIC NEUROLOGICAL SYNDROMES, POTASSIUM CHANNEL ANTIBODY, SYSTEMIC-LUPUS-ERYTHEMATOSUS, EPILEPSIA PARTIALIS CONTINUA, CENTRAL-NERVOUS-SYSTEM, CELL LUNG-CARCINOMA, ANTI-MA2-ASSOCIATED ENCEPHALITIS, OVARIAN TERATOMA, DEVELOPMENTAL PROTEIN, ENCEPHALOMYELITIS

Abstract

Background and Objective: Recent studies suggest that a substantial number of patients with autoimmune limbic encephalitis may improve if properly diagnosed and treated. This is due, in part, to the increasing recognition of disorders that associate with antibodies to neuronal cell membrane antigens. This review focuses in these disorders, trained in a clinically useful immunologic classification of limbic encephalitis.